financetom
Business
financetom
/
Business
/
MetroCity Bankshares' Q2 net interest income rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MetroCity Bankshares' Q2 net interest income rises
Jul 18, 2025 7:44 AM

Overview

* Metrocity's Q2 net income rises 3.2% from Q1, driven by higher interest income

* Net interest margin improves to 3.77% from 3.67% in Q1

* Company receives regulatory approval for merger with First IC Corporation

Outlook

* Company expects merger with First IC to complete in Q4 2025

Result Drivers

* INTEREST INCOME - Increase in net interest income driven by higher average interest-earning cash and fed funds sold balance and increased loan yield

* NONINTEREST INCOME - Gains from residential mortgage loans and SBA loan sales contributed to higher noninterest income

* MERGER EXPENSES - Noninterest expenses increased due to First IC merger-related costs and higher employee benefits

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 EPS $0.65

Q2 Net $16.83

Income mln

Q2 Net $32.18

Interest mln

Income

Q2 CET1 19.9%

Ratio

Q2 Loan $129,000

Loss

Provisio

n

Q2 Net 3.8%

Interest

Margin

Analyst Coverage

* The one available analyst rating on the shares is "hold"

* The average consensus recommendation for the banks peer group is "buy."

* Wall Street's median 12-month price target for Metrocity Bankshares Inc ( MCBS ) is $34.00, about 13.8% above its July 17 closing price of $29.32

* The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 10 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Panther Minerals Down 3.1% as it Signs Non-Binding Letter of Intent to Buy Huber Heights Uranium Property
Update: Panther Minerals Down 3.1% as it Signs Non-Binding Letter of Intent to Buy Huber Heights Uranium Property
Jul 9, 2024
11:31 AM EDT, 07/09/2024 (MT Newswires) -- Panther Minerals ( GLIOF ) said Tuesday that it signed a non-binding letter of intent to acquire 148 BC, which holds the Huber Heights uranium property in Nevada. Under the terms, Panther will issue 5 million shares and pay $20,000 on execution of a definitive agreement. Panther said the acquisition is part of...
Synopsys Insider Sold Shares Worth $20,550,399, According to a Recent SEC Filing
Synopsys Insider Sold Shares Worth $20,550,399, According to a Recent SEC Filing
Jul 9, 2024
11:27 AM EDT, 07/09/2024 (MT Newswires) -- Aart De Geus, Director, Executive Chair, on July 05, 2024, sold 33,201 shares in Synopsys ( SNPS ) for $20,550,399. Following the Form 4 filing with the SEC, De Geus has control over a total of 430,274 shares of the company, with 106,983 shares held directly and 323,291 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/883241/000151773724000085/xslF345X03/edgardoc.xml...
Broadcom Issues $5B in Debt To Fund VMware Acquisition
Broadcom Issues $5B in Debt To Fund VMware Acquisition
Jul 9, 2024
Broadcom Inc ( AVGO ) borrowed $5 billion in the U.S. investment-grade bond market on Monday to refinance some of the loans it secured for its $69 billion acquisition of VMware Inc. The software developer sold debt in three parts, Bloomberg cites a familiar source. After initial talks, the longest tranche yields 0.95 percentage points over Treasuries, approximately 1.25 percentage...
Tempus AI Poised for 27% Topline Growth Through 2028, Morgan Stanley Says
Tempus AI Poised for 27% Topline Growth Through 2028, Morgan Stanley Says
Jul 9, 2024
11:29 AM EDT, 07/09/2024 (MT Newswires) -- Tempus AI's ( TEM ) topline is expected to increase at a 27% compound annual growth rate to $1.8 billion in 2028 from $532 million last year, Morgan Stanley said Tuesday in a report. While near-term revenue generation will hinge on the genomics business, which represents two-thirds of sales today, we see significant...
Copyright 2023-2026 - www.financetom.com All Rights Reserved